JBC Invitrogen Ultrasensitive Cytokine Assays

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, Y. P.
Right arrow Articles by Guy, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, Y. P.
Right arrow Articles by Guy, G. R.

J Biol Chem, Vol. 274, Issue 27, 19025-19034, July 2, 1999

Association of Atypical Protein Kinase C Isotypes with the Docker Protein FRS2 in Fibroblast Growth Factor Signaling

Yoon Pin Lim, Boon Chuan Low, Jormay Lim, Esther Sook Miin Wong, and Graeme R. Guy

From the Signal Transduction Laboratory, Institute of Molecular and Cell Biology, National University of Singapore, 30 Medical Drive, Singapore 117609, Republic of Singapore

FRS2 is a docker protein that recruits signaling proteins to the plasma membrane in fibroblast growth factor signal transduction. We report here that FRS2 was associated with PKC lambda  when Swiss 3T3 cells were stimulated with basic fibroblast growth factor. PKC zeta , the other member of the atypical PKC subfamily, could also bind FRS2. The association between FRS2 and PKC lambda  is likely to be direct as shown by yeast two-hybrid analysis. The C-terminal fragments of FRS2 (amino acid residues 300-508) and SNT2 (amino acids 281-492), an isoform bearing 50% identity to FRS2, interacted with PKC lambda  at a region (amino acids 240-562) that encompasses the catalytic domain. In vitro kinase assays revealed neither FRS2 nor SNT2 was a substrate of PKC lambda  or zeta . Mutation of the alanine residue (Ala-120) to glutamate in the pseudo-substrate region of PKC lambda  results in a constitutively active kinase that exhibited more than 2-fold greater binding to FRS2 in vitro than its "closed" wild-type counterpart. Tyrosine phosphorylation of FRS2 did not affect its binding to the constitutively active PKC lambda  mutant, suggesting that the activation of PKC lambda  is necessary and sufficient for its association with FRS2. It is likely that FRS2 serves as an anchoring protein for targeting activated atypical PKCs to the cell plasma membrane in signaling pathways.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton
Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction
Endocr. Rev., April 1, 2008; 29(2): 193 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. A. Wald, A. S. Oriolo, A. Mashukova, N. L. Fregien, A. H. Langshaw, and P. J. I. Salas
Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells
J. Cell Sci., March 1, 2008; 121(5): 644 - 654.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
Y. Chen, L.-Y. Choong, Q. Lin, R. Philp, C.-H. Wong, B.-K. Ang, Y.-L. Tan, M.-C.-S. Loh, C.-L. Hew, N. Shah, et al.
Differential Expression of Novel Tyrosine Kinase Substrates during Breast Cancer Development
Mol. Cell. Proteomics, December 1, 2007; 6(12): 2072 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L.-Y. Choong, S. Lim, M. C.-S. Loh, X. Man, Y. Chen, W. Toy, M. Pan, C.-S. Chen, A. Poonepalli, M. P. Hande, et al.
Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: implications in target-directed therapeutics
Mol. Cancer Ther., November 1, 2007; 6(11): 2828 - 2842.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. L. Kirby, L. Yang, J. C. Labus, and B. T. Hinton
Characterization of Fibroblast Growth Factor Receptors Expressed in Principal Cells in the Initial Segment of the Rat Epididymis
Biol Reprod, June 1, 2003; 68(6): 2314 - 2321.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Ridyard and S. M. Robbins
Fibroblast Growth Factor-2-induced Signaling through Lipid Raft-associated Fibroblast Growth Factor Receptor Substrate 2 (FRS2)
J. Biol. Chem., April 11, 2003; 278(16): 13803 - 13809.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. V. Fedorov, N. C. Jones, and B. B. Olwin
Atypical Protein Kinase Cs Are the Ras Effectors That Mediate Repression of Myogenic Satellite Cell Differentiation
Mol. Cell. Biol., February 15, 2002; 22(4): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Yusoff, D.-H. Lao, S. H. Ong, E. S. M. Wong, J. Lim, T. L. Lo, H. F. Leong, C. W. Fong, and G. R. Guy
Sprouty2 Inhibits the Ras/MAP Kinase Pathway by Inhibiting the Activation of Raf
J. Biol. Chem., January 25, 2002; 277(5): 3195 - 3201.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Feraille and A. Doucet
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Physiol Rev, January 1, 2001; 81(1): 345 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Gaubert, F. Escaffit, C. Bertrand, M. Korc, L. Pradayrol, F. Clemente, and A. Estival
Expression of the High Molecular Weight Fibroblast Growth Factor-2 Isoform of 210 Amino Acids Is Associated with Modulation of Protein Kinases C delta and epsilon and ERK Activation
J. Biol. Chem., January 5, 2001; 276(2): 1545 - 1554.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. R. Burgar, H. D. Burns, J. L. Elsden, M. D. Lalioti, and J. K. Heath
Association of the Signaling Adaptor FRS2 with Fibroblast Growth Factor Receptor 1 (Fgfr1) Is Mediated by Alternative Splicing of the Juxtamembrane Domain
J. Biol. Chem., February 1, 2002; 277(6): 4018 - 4023.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.